Ocular Therapeutix Inc
(NASDAQ : OCUL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.10%19.7014.1%$436.29m
SAGESAGE Therapeutics, Inc.
2.72%162.3210.9%$216.91m
SHPGShire PLC Sponsored ADR
2.77%151.270.4%$168.46m
PRGOPerrigo Co. Plc
2.93%86.506.6%$88.44m
MNKMallinckrodt Plc
1.08%23.3618.5%$79.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.47%130.217.6%$59.41m
UTHRUnited Therapeutics Corporation
1.20%137.4114.5%$56.06m
JAZZJazz Pharmaceuticals Plc
0.02%135.532.2%$56.04m
ICPTIntercept Pharmaceuticals, Inc.
0.02%61.6222.0%$40.25m
RVNCRevance Therapeutics, Inc.
-0.31%32.0512.2%$36.88m
CTLTCatalent Inc
2.65%41.122.6%$36.60m
MDCOMedicines Company
0.18%27.3022.1%$36.53m
ADMSAdamas Pharmaceuticals, Inc.
1.56%32.5816.9%$36.42m
ENDPEndo International Plc
2.43%8.008.9%$33.43m
PTLAPortola Pharmaceuticals, Inc.
-1.12%47.027.8%$33.19m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its products include dextenza, sustained release travopost, and posterior segment injections. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.